Andrea Malaspina is a Professor of Neurology and the Clinical Academic Lead of the Queen Square Motor Neuron Disease Centre, Institute of Neurology, UCL. After obtaining a PhD in Molecular Neurobiology from Imperial College London, he has worked as a Consultant Neurologist at Barts Health and founded the local MND Care and Research Centre with an active role in Clinical Neurology and research interests in neuromuscular and motor cell disorders. In 2009, he founded the Barts Health MND Care and Research Centre. In 2012, he took up a formal academic appointment as Clinical Senior Lecturer with the Barts and The London Medical School and as Professor of Neurology Neurology from 2019. He has been responsible for MND research in the North-Thames LCRN and has led the Neurodegeneration Research Group at the Blizard Institute, London.
Andrea Malaspina leads a multi-disciplinary research group in the field of biomarkers and therapeutic targets discovery in neurodegeneration. His research focuses on the identification and characterization of biological signals that reflect the risk of developing a neurodegenerative pathology, predict its rate of progression and response to treatment. This multi-modal approach is applied to Motor Neuron Disease to unravel the biological mechanisms behind onset and propagation of the neurodegenerative process. He has contributed to the establishment and development of large bio-banking projects for neurodegenerative disorders, including the ALS biomarkers study and A Multicentre Biomarker Resource Strategy in ALS (AMBRoSIA), combining longitudinal collection and novel concepts for storage and biochemical assays optimization.